GammaDelta Therapeutics
London
About GammaDelta Therapeutics
GammaDelta Therapeutics is developing the potential of gamma delta (╬│╬┤) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident ╬│╬┤ T cells for effective immunotherapy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Sep 2016)
- Website: gammadeltatx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Canonical: https://fsome.com/organization/gammadelta-therapeutics-2703535 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.